You are here: Industry Insights > chemotherapy

News List

Full Chemo Doses May Improve Survival in Breast Cancer drugs
September 12, 2019
Maintaining full doses of chemotherapy, especially early in the treatment course, is important for survival of intermediate or high-risk breast cancer patients...
Chemotherapy is Out-of-date? Global Chemotherapy Demands will be Doubled in 2040, with China Having the Highest Demands! PharmaSources/Yefenghong
September 04, 2019
Many people consider that the status of chemotherapy in cancer treatment has fallen considerably and some even consider chemotherapy to be out-of-date in recent years with the occurrence of targeted drugs and immunotherapy. Is chemotherapy useless?
Drug accelerates blood system's recovery after chemotherapy, radiation worldpharmanews
August 16, 2019
A drug developed by UCLA physician-scientists and chemists speeds up the regeneration of mouse and human blood stem cells after exposure to radiation. If the results can be replicated in humans...
Global Patients Whining about the Production Suspension of the Cytarabine Manufacturer PharmaSources/Shanghai Xiaoyaoshi
July 01, 2019
Manufacturing delayed due to the manufacturer’s overhaul; production suspension leading to a shortage in the world
Pembrolizumab trumps chemotherapy in recurrent head and neck cancer pharmaceutical-technology
June 05, 2019
Research has shown that immunotherapy pembrolizumab alone and in combination with chemotherapy is a more efficacious first line treatment for head and neck cancer that has returned than aggressive chemotherapy.
Iovance Biotherapeutics Announces Breakthrough Therapy Designation for LN-145 for Treatment of Advanced Cervical Cancer Patients Who Have Progressed on or After Chemotherapy drugs
May 30, 2019
Iovance Biotherapeutics Announces Breakthrough Therapy Designation for LN-145 for Treatment of Advanced Cervical Cancer Patients Who Have Progressed on or After Chemotherapy.
UNSW study predicts more than 50% rise in chemotherapy demand by 2040 biospectrumasia
May 15, 2019
The modelling study by a team of researchers – including UNSW Medicine academics – was published recently
Targovax Announces Completed Enrollment of ONCOS-102 Trial in Mesothelioma prnewswire
May 08, 2019
Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces that it has completed patient enrollment in the phase...
NIR identifies breast cancer patients who will benefit from chemotherapy europeanpharmaceuticalreview
April 29, 2019
Scientists have developed a new optical imaging system that uses red and near-infrared light (NIR) to identify breast cancer patients who will respond to chemotherapy.
NIR identifies breast cancer patients who will benefit from chemotherapy europeanpharmaceuticalreview
April 29, 2019
Scientists have developed a new optical imaging system that uses red and near-infrared light to identify breast cancer patients who will respond to chemotherapy…

Previous page 1 2 3 4 5 Next page